SCHEMBL24625640

SCHEMBL24625640

CN1CCN(c2ccc(N)c(CC(F)F)c2F)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 5/20 0.44
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
PTK2B Q14289 2/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
ADRA2C P18825 3/20 0.44
POLB P06746 1/20 0.43
RAD52 P43351 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GFER P55789 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR2 Q92731 1/20 0.36
HTR6 P50406 3/20 0.35
NCF1 P14598 2/20 0.35
HRH4 Q9H3N8 4/20 0.35
WDR5 P61964 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28425579 0.84 ALDH1A1 (0.54) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL10061518 0.84 ALDH1A1 (0.54) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL16514423 0.78 ALDH1A1 (0.62) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL2894409 0.77 ALDH1A1 (0.60) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL30464713 0.75 ALDH1A1 (0.58) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL22471212 0.75 ALDH1A1 (0.58) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL22164011 0.75 ALDH1A1 (0.54) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL29771873 0.74 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL24625641 0.74 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EMAPTGAA
SCHEMBL24620621 0.74 ALDH1A1 (0.57) ALDH1A1L3MBTL1KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147620-A1 THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-07-14 WO disclosed